Rare diseases
Investigational molecules
Locations
Study of [177Lu]Lu-NeoB and Capecitabine for Patients with Advanced Breast Cancer Resistant to Hormone Therapy
FranceStudy Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma
FranceStudy of Farletuzumab Ecteribulin for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
FranceStudy of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
FranceStudy of IPN01194 for Adults with Advanced Solid Tumors, Including Melanoma, Head and Neck Cancer, Pancreatic Cancer, and Colorectal Cancer
FranceStudy of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
FranceStudy on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment
FranceStudy of nivolumab, relatlimab and bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)
FranceStudy on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis
FranceStudy on the Long-Term Safety and Effectiveness of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)
FranceStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations
FranceStudy of Mavacamten for Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
